'Deadly Risk' of Fat-Loss Drugs
Newsweek Europe|March 22, 2024
Diabetes treatment Ozempic has become popular among dieters due to its weightloss side effect, but a study warns of a link between the drug and suicidal thoughts
PANDORA DEWAN
'Deadly Risk' of Fat-Loss Drugs

"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.

The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.

Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.

In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.

Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.

The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.

Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.

Denne historien er fra March 22, 2024-utgaven av Newsweek Europe.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra March 22, 2024-utgaven av Newsweek Europe.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA NEWSWEEK EUROPESe alt
The Next Phase of War
Newsweek Europe

The Next Phase of War

After thousands of elite soldiers from North Korea joined Vladimir Putin’s forces against Ukraine, how has this latest move affected the conflict?

time-read
6 mins  |
November 29, 2024
Hey, Don't Be So SAD
Newsweek Europe

Hey, Don't Be So SAD

Seasonal affective disorder affects millions of people. Here’s how you can prep your body and mind for darker days

time-read
5 mins  |
November 29, 2024
America's Best CONTINUING CARE
Newsweek Europe

America's Best CONTINUING CARE

EDUCATIONAL OPPORTUNITIES, RESTAURANTstyle dining, unlimited pickleball-an impressive number of amenities are becoming standard at Continuing Care Retirement Communities.

time-read
4 mins  |
November 29, 2024
NEW WORLD ORDER
Newsweek Europe

NEW WORLD ORDER

HOW LEADERS ACROSS THE GLOBE ARE REACTING TO DONALD TRUMP'S REELECTION AS U.S. PRESIDENT

time-read
10+ mins  |
November 29, 2024
My Fight for Equality and Justice
Newsweek Europe

My Fight for Equality and Justice

It will take more than just science to end AIDS. Inclusion, empathy and compassion are essential, too

time-read
3 mins  |
November 29, 2024
Saying No to Trump and Men
Newsweek Europe

Saying No to Trump and Men

The election has led some women to boycott relationships and sex

time-read
7 mins  |
November 29, 2024
Wendi McLendon-Covey
Newsweek Europe

Wendi McLendon-Covey

AFTER 10 YEARS OF PLAYING BEVERLY GOLDBERG ON THE GOLDBERGS, Wendi McLendon-Covey was not eager for a break. \"I need to go do a job where I can just throw everything at it and then come home totally exhausted.\"

time-read
1 min  |
November 22, 2024
'I'm the Highest Earner in Esports'
Newsweek Europe

'I'm the Highest Earner in Esports'

Johan \"NOtail\" Sundstein has won over $7 million but says, \"I don't really crave that status...I play for my own reasons\"

time-read
6 mins  |
November 22, 2024
AMERICA'S BEST Weight Loss CLINICS & CENTERS 2025
Newsweek Europe

AMERICA'S BEST Weight Loss CLINICS & CENTERS 2025

WHETHER IT'S FOR MEAL PLANS, PROFESSIONAL guidance or access to medications like GLP-1s, weight loss clinics can offer personalized assistance for those hoping to make sustainable lifestyle changes.

time-read
3 mins  |
November 22, 2024
AMERICA'S MOST ANTICIPATED NEW VEHICALS - 2025
Newsweek Europe

AMERICA'S MOST ANTICIPATED NEW VEHICALS - 2025

WHETHER IT'S A NEWLY IMAGined sport utility vehicle or the re-emergence of a highly regarded halo car, the vehicles coming to market in 2025 prove that Americans' attitudes about personal transportation are diverse and are being served from all angles.

time-read
10+ mins  |
November 22, 2024